证券之星消息，根据天眼查APP于4月21日公布的信息整理，英纳瑞医疗科技(上海)有限公司A轮融资，融资额千万级人民币，参与投资的机构包括国泰君安创投，贝壳社。 英纳瑞医疗成立于2022年，总部位于上海市，专注于提供全生命周期骨代谢管理全流程解决方案，致力于骨健康诊疗设备及人工智能大模型项目发展，业务模块涵盖了骨质疏松筛查、诊断、药物疗效评估、预防跌倒和家用骨痛治疗等五大板块，并通过自主创新的医疗设备和人工智能平台开展分级诊疗管理模式，联合多家知名三甲医院共同打造标准化骨代谢诊疗中心(BMC)，为患者提供全方位的骨健康诊疗设备及人工智能工作站，打通社区医院最后一公里的服务。数据来源：天眼查APP为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.